Embil Pharmaceuticals

Embil Pharmaceuticals is a long-standing Turkish pharmaceutical company founded in 1924, specializing in the development, manufacturing, and marketing of specialty medicines. The company focuses primarily on therapeutic areas such as dermatology, gynecology, and pediatrics, maintaining a significant presence in the Turkish healthcare market. In 2014, Embil was acquired by the Italian pharmaceutical group Recordati, which integrated Embil's portfolio and manufacturing capabilities into its international operations. The company operates a GMP-certified production facility in Çerkezköy, Turkey, where it produces a variety of dosage forms including solids, semi-solids, and liquids. Embil is recognized for its strong brand heritage and its role as both a product developer and a contract manufacturing partner. Today, it serves as a strategic hub for Recordati's activities in the region.